 |
Two drugs don't boost lung cancer survival: RocheRoche Holding and Genentech said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival. Both drugs are targeted therapies -- modern medicines More… |
Sunday 19 May 2024
